ArticleNeuro-oncology practice2025
Symptom distress and treatment interest for cognitive decline in neuro-oncology.
Article in Neuro-oncology practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adult patients with brain tumors experience cognitive, physical, and emotional sequelae from the disease and treatment. Cognitive changes, in particular, are a common source of distress and can be treated using varied approaches. Establishing the relationship between sources of distress and understanding patient preferences for treatment of cognitive change is necessary for future integrative neurocognitive programmatic development. Methods: Neuro-oncology patients (primary and metastatic) reported their distress related to common neuro-oncology disease symptoms, treatment preferences for cognitive change (e.g., cognitive rehabilitation, mindfulness training, psychotherapy, medication), and a measure of subjective cognition. Demographics and tumor characteristics were self-reported. Descriptive statistics, correlations, and Results: One hundred thirty-seven patients ( Conclusions: Neuro-oncology patients reported distress due to cognitive changes more frequently than distress due to other disease sequelae (e.g., mood changes, physical symptoms), and this was robust across patient demographics and disease characteristics. Patients reported high interest in cognitive rehabilitation, mindfulness training, and psychotherapy for management of cognitive concerns, suggesting the need for non-pharmacological multi-modal interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.